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Summary C3H/He mice bearing SCC VII tumours received 5-bromo-2'-deoxyuridine (BrdU) continuously for 5 days via implanted mini-
osmotic pumps in order to label all proliferating (P) cells. The tumours were then heated at 400C for 60 min. At various time points after
heating, tumour-bearing mice were irradiated while alive or after being killed. Immediately after irradiation, the tumours were excised, minced
and trypsinized. The tumour cell suspensions obtained were incubated with cytochalasin-B (a cytokinesis blocker), and the micronucleus
(MN) frequency in cells without BrdU labelling, which could be regarded as quiescent (Q) cells, was determined using immunofluorescence
staining for BrdU. The MN frequency in the total (P+Q) tumour cell population was determined from the irradiated tumours that were not
pretreated with BrdU. The MN frequency of BrdU unlabelled cells was then used to calculate the surviving fraction of the unlabelled cells from
the regression line for the relationship between the MN frequency and the surviving fraction of total (P+Q) tumour cells. In general, Q cells
contained a greater hypoxic fraction (HF) than the total tumour cell population. Mild heating decreased the HF of Q cells more markedly than
in the total cell population, and the minimum values of HFs of both total and Q cell populations were obtained 6 h after heating. Two days after
heating, the HF of total tumour cells returned to almost that of unheated tumours. In contrast, the HF of Q cells did not return to the HF level
of unheated tumours until 1 week after heating. It was thought that irradiation within 12 h after mild heating might be a potentially promising
therapeutic modality for controlling radioresistant Q tumour cells.
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Tumour hypoxia is clearly an important problem, and improved
patient responses to radiotherapy can be achieved by treatments
that overcome tumour radiation resistance resulting from the pres-
ence ofhypoxic cells (Overgaard, 1989). It has been firmly estab-
lished that hypoxic cells impair the radiation responsiveness of
almost all animal tumours thus far investigated (Coleman, 1988).
The effectiveness of hyperthermia as an adjuvant modality to
radiotherapy has been demonstrated (Overgaard et al, 1995).
Laboratory experiments using animal tumours showed that heating
for 30 to 60 min at relatively high temperatures, i.e. > 43 to 44°C,
damages intratumour blood vessels and kills tumour cells (Vaupel,
1990). Additionally, hyperthermia causes direct cellular radio-
sensitization (Dewey, 1994). However, currently available hyper-
thermia devices have been ineffective in raising the temperature of
human tumours sufficiently to cause such effects. Furthermore,
according to clinical results of thermoradiotherapy, correlations
between response to hyperthermia and lowest temperatures in
tumours have been reported, and the prognostically important
temperatures have been < 41C (Valdagni et al, 1988; Oleson et al,
1993). Therefore, Oleson (1995) suggested that in previous clin-
ical studies in which hyperthermia was shown to improve the
effectiveness of radiotherapy, it might have improved tumour
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oxygenation, and thus indirectly radiosensitized tumours through
an increase in tumour blood flow.
On the other hand, it is known that many tumour cells in solid
tumours are non-proliferating (quiescent) and it has been shown
that plateau-phase cultures in vitro contain large numbers ofquies-
cent (Q) cells (Luk and Keng, 1985). Over the last 25 years, the
nature of Q cells has been extensively examined. However, many
aspects of these cells are still unknown (Jackson, 1989).
Accordingly, to improve the treatment of cancer, the responses of
Q cells in solid tumours to various anti-cancer therapeutic modali-
ties should be determined, as many tumour cells are quiescent in
situ but are still clonogenic (Steel, 1977).
In this study, we analysed time courses of changes in the
hypoxic fractions oftotal [proliferating (P)+Q] and Q-cell popula-
tions within murine solid tumours in situ (SCC VII squamous cell
carcinoma) after hyperthermia at mild temperatures, using our
recently developed method for selectively detecting the irradiation
response of Q cells in solid tumours (Masunaga et al, 1991). Our
results indicated that mild hyperthermia might preferentially
oxygenate the chronically hypoxic fraction.
MATERIALS AND METHODS
Tumours, mice and labelling with BrdU
SCC VII squamous cell carcinomas derived from C3H mice were
maintained in vitro in Eagle's minimum essential medium
containing 12.5% fetal bovine serum. Cells were collected from
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monolayer cultures, and approximately 1.0 x 105 cells were inocu-
lated subcutaneously into the left hind legs of 8- to 11-week-old
syngeneic female C3H/He mice. Fourteen days after inoculation,
the tumours had reached approximately 1 cm in diameter. Nine
days after inoculation, mini-osmotic pumps (Alzet model 2001
or 2002, USA), containing 5-bromo-2'-deoxyuridine (BrdU)
dissolved in physiological saline (250 mg ml-') were implanted
subcutaneously for 5 days to allow continuous labelling.
Administration of BrdU did not change the tumour growth rates.
The tumours were 1 cm in diameter upon treatment. The labelling
index after 5 days of continuous labelling with BrdU was
55.3 ± 4.5% (mean ± s.d.), and reached a plateau at this stage.
Therefore, in this study, we regarded tumour cells not incorpo-
rating BrdU after continuous labelling as Q cells.
Treatment
After labelling with BrdU, the tumours grown in the left hind legs
ofmice were heated at40°C for60 min in a waterbath. As we used
the same kind of tumour system and the same tumour size upon
heating as Nishimura et al (1988), we used the same heating
method as they did. In general, temperatures at the tumour centre
equilibrated within 3 or4 min afterimmersion in the waterbath and
remained 0.2-0.3°C below the waterbath temperature. The temper-
ature difference between the tumour centre and the periphery was
within 0.1°C. The water bath temperature was maintained 0.3°C
above the desired tumour temperature and all temperatures refer to
the tumour temperature. The tumour-bearing mice then received
whole-body irradiation of 20-28 Gy from a cobalt-60 y-ray irradi-
ator at a dose rate of5.97 Gy min-', 0, 3, 6, 12, 24, 48, 72 or 168 h
after heating. Where tumours were not heated, mice received
whole-body irradiation of 18-29 Gy. Tumour-bearing mice were
irradiated while alive without receiving any treatment. Other
tumour-bearing mice were killed by cervical dislocation 5 min
before irradiation, and then irradiated with no further treatment.
Each treatment group included micepretreated with and without
BrdU. The tumours were excised immediately after irradiation.
Immunofluorescence staining of BrdU-Iabelled cells
and observation of micronucleus formation
These procedures have been described in detail elsewhere
(Masunaga et al, 1991). After the above-mentioned treatments,
excised tumours from mice given BrdU were minced and
trypsinized at 370C for 15 min, using 0.05% trypsin and 0.02%
ethylenediamine tetraacetic acid (EDTA). Tumour cell suspen-
sions were inoculated in 60-mm tissue culture dishes, containing
5 ml of complete medium and 1.0 ,ug ml-} of cytochalasin-B to
inhibitcytokinesis while allowing nuclear division. The proportion
of binuclear cells reached a maximum 48 h after the initiation of
the cultures. The cultures were trypsinized and single cell suspen-
sions were fixed with 70% ethanol. After centrifugation, the cell
pellet was resuspended with 0.4 ml ofcold Camoy's fixative. The
suspension (30 ,ul) was then placed on a glass microscope slide
using a dropper and the sample was dried at room temperature.
The slides were treated with 2 M hydrochloric acid for 30 min at
room temperature to dissociate the histones and partially denature
the DNA. The slides were then immersed in borax-borate buffer
(pH 8.5) to neutralize the acid. BrdU-labelled cells were detected
by indirect immunofluorescence staining using monoclonal anti-
BrdU antibody (Becton Dickinson, USA) and fluorescein isothio-
cyanate (FITC)-conjugated anti-mouse IgG antibody (Sigma,
USA). To observe double staining of tumour cells with FITC and
propidium iodide (PI), cells on the slides were treated with 30jl of
PI [1-5 jg ml-' in phosphate-buffered saline (PBS)] while under
the fluorescence microscope. When the intensity of the red fluo-
rescence produced by PI became similar to the intensity of the
green fluorescence in nuclei prestained with FITC, the treatment
was stopped by rinsing the slide with water. The micronucleus
(MN) frequency in unlabelled Q cells could be examined by
counting the micronuclei in those binuclear cells that showed only
red fluorescence. The MN frequency was defined as the ratio of
the number of micronuclei in the binuclear cells to the total
number ofbinuclear cells observed (Ono et al, 1989).
The ratio obtained in tumours not pretreated with BrdU indi-
cated the MN frequency of all phases of the total tumour (P+Q)
cell populations.
The MN frequency of BrdU-labelled cells, which could be
regarded as P cells upon treatment, was modified because the
radiosensitization effect of the incorporated BrdU (Mitchell et al,
1984) has the potential to influence the frequency ofmicronucleus
and binuclear cell appearance in BrdU-labelled cells. Therefore,
the correct MN frequency ofP cells without BrdU effect could not
be obtained. In addition, during the continuous labelling with
BrdU over 5 days, the shift ofcells from the P to the Q population
can result in labelled Q cells. These cells were excluded when we
scored micronuclei in binuclear cells showing only red fluores-
cence by PI, because these cells were stained with FITC.
Cell survival assay
The cell survival assay was also performed in mice given no
BrdU using an in vivo-in vitro assay method. Excised tumours
were disaggregated by stirring for 15 min at 37°C in PBS
containing 0.05% trypsin and 0.02% EDTA. The cell yield was
4.5 ± 1.1 x 107 g-'. The plating efficiencies for the total tumourcell
population and the MN frequencies forQ and the total cell popula-
tions in the tumours at 0 Gy ofirradiation are shown in Table 1.
Determination of cell survival curves of cells not
labelled by BrdU
In each paired experiment, the MN frequency in cells not incorpo-
rating BrdU was translated to the surviving fraction, using the
regression line for the relationship between the normalized MN
frequency (MN frequency - C, where C is the MN frequency in
unirradiated tumours) and the surviving fraction determined for
total cells in tumours from mice not pretreated with BrdU in each
group. Thus, the cell survival curve ofnon-incorporating cells was
determined for each treatment.
Measurement of the hypoxic fraction (HF)
To determine the HF of the tumours, the paired survival curve
method was used (Moulder and Rockwell, 1984). Hypoxia was
induced in mice killed by cervical dislocation 5 min before irradi-
ation. The best parallel lines were fitted to the two survival curves,
and the HF ± 95% confidence limits were determined from the
vertical displacement of the two lines. To determine the HF,
analysis ofcovariance was performed.
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Table 1 Plating efficiencies and micronucleus frequencies at 0 Gy
Plating efficiency (%) Micronucleus frequency
Total tumour Total tumour Quiescent cell
cell population cell population population
Heating (-) 57.9 (49.7-66.1)- 0.049 (0.037-0.061) 0.062 (0.049-0.075)
Heating (+)
0 h later 59.8 (50.8-68.8) 0.059 (0.047-0.071) 0.075 (0.059-0.091)
3 h later 50.1 (45.9-54.3) 0.053 (0.042-0.064) 0.067 (0.053-0.081)
6 h later 62.2 (52.1-72.3) 0.053 (0.043-0.063) 0.063 (0.050-0.076)
12 h later 46.9 (35.7-58.1) 0.052 (0.043-0.061) 0.081 (0.063-0.099)
24 h later 49.9 (42.6-57.2) 0.051 (0.042-0.060) 0.063 (0.051-0.075)
48 h later 59.6 (47.5-71.7) 0.051 (0.040-0.062) 0.077 (0.060-0.094)
72 h later 47.1 (38.3-55.9) 0.050 (0.042-0.058) 0.077 (0.062-0.092)
168 h later 58.2 (50.1-66.3) 0.060 (0.047-0.073) 0.079 (0.063-0.095)
aNumbers in parentheses are 95% confidence limits, determined using mean values, standard deviations and the numbers of observations on
which the means and the standard deviations were based.
Oh 3h 6 h 12 h
101 \* 101 t
10-2 10-2\
10-3 InY = - 4.05X 10-3 nY=-4.18X
r = -0.91 \ r= -0.94
104 f1~P<0.001 _ P< 0.001
10-4 004
1.5 0 0.5 1 1.5 0 0.5 1 1.5
72 h
1o-0
100
\102
InY=-4.07X -41 l
r= -0.96
P< 0.001
10-4
168 h
.\+
\Z
InY = - 4.32X
r= -0.91
P< 0.001
0 0.5 1 1.5 0 0.5 1.5 0 0.5 1 1.5 0 0.5 1 1.5
Figure 1 Correlation between the normalized micronucleus frequency (micronucleus frequency -C, where C is the micronucleus frequency in cells from
animals not treated with radiation) and the surviving fraction for total tumour cell populations obtained from the assays performed without heating, and 0, 3, 6,
12, 24, 48, 72 and 168 h after heating. Tumours irradiated while the animals were alive (0) or after being killed (@). The respective regression lines are In Y =
-3.14 X, In Y = -3.57 X, In Y = -3.94 X, In Y = -4.05 X, In Y = -4.18 X, In Y = -4.00 X, In Y = -4.12 X, In Y = -4.07 X, andin Y = -4.32 X (X = normalized
micronucleus frequency, Y = surviving fraction). Bars represent standard deviations
Four mice were used to assess each set of conditions and each
experiment was repeated three times. To examine the differences
between pairs of values, Student's t-test was used when variances
of the two groups could be assumed to be equal, otherwise the
Welch t-test was used.
RESULTS
The correlation between the normalized MN frequency and the
surviving fraction of the total tumour cell population in SCC VII
tumours for each treatment is shown in Figure 1. The regression
lines for heated tumours were almost the same.
The dose-survival curves for each treatment are shown in
Figure 2. Overall, the surviving Q-cell fractions were significantly
greater than those for total tumour cells in each treatment group
(P < 0.05), especially in normally aerated tumours. The HFs of
total and Q tumour cell populations in normally aerated tumours
were calculated from the best paired survival curves drawn by
comparison between normally aerated tumours in living mice and
totally hypoxic tumours in dead mice using the data in Figure 2.
Figure 3 shows the time courses ofchanges in the HFs ofQ and
total (P+Q) tumour cell populations after mild hyperthermic treat-
ment. In general, the HF of Q cells was significantly higher
than that for the total tumour cells for each treatment (P < 0.05).
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Figure 2 Cell survival curves for total tumour cell populations (circles) and quiescent cells (squares) obtained from the assays performed without heating, and
0, 3, 6, 12, 24, 48, 72 and 168 h after heating. Tumours irradiated while the animals were alive or after being killed are shown by open and solid symbols
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4
50 100 150
Time after heating (h)
Heat (-)
Figure 3 Changes in the hypoxic fractions of total (0) and quiescent (E)
tumour cell populations after heating. The hypoxic fractions of total (@) and
quiescent (U) tumour cell populations when tumours were not heated. Bars
represent 95% confidence limits
HF values declined until 6 h after mild heating at which time they
showed the lowest values. Subsequently, HF slowly returned
towards the value obtained when tumours were not heated. Two
days after heating, the HF of total tumour cell populations had
almost recovered to the level in unheated controls. However, the
HF of Q cells did not return to that in unheated tumours until
168 h (= 1 week) after heating. The ratios of the minimum value
of HF at 6 h after heating to that in unheated tumours were
31.3 ± 8.5% and 54.3 ± 14.2% for Q and total tumour cells
respectively. Thus, mild heat treatment decreased the HF of Q
cells more markedly than that ofthe total tumour cell population.
DISCUSSION
The presence ofQ cells within a tumour is thought to influence its
responsiveness to various treatments (Steel, 1977). Q cells in solid
tumours are thought to be in this state partly because of oxygen
and nutrient deprivation (Dethlefsen, 1980). However, the charac-
terization of Q cells in solid tumours and analysis of their sensi-
tivity to various treatments have been greatly hampered by the
lack of adequate techniques to identify such cells and to obtain
them in large homogeneous populations. Accordingly, we recently
developed amethod forthe selective determination ofresponses of
Q cells in solid tumours (Masunaga et al, 1991).
Our previous in vitro studies showed that the radiosensitivity of
those cells that did not incorporate BrdU after pulse labelling the
exponentially growing cultures could be determined accurately
from the MN frequency (Masunaga et al, 1990). Moreover, we
showed the usefulness of a modification of this in vitro method
for assessing the radiosensitivity of Q cells in solid tumours
(Masunaga etal, 1991). Therefore, it is an acceptable way to deter-
mine the surviving fractions of Q cells from their normalized
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MN frequency data, using the regression line for the relationship
between the normalized MN frequency and the surviving fraction
determined for the total tumour cell population.
It has been reported that solid tumours contain hypoxic cells
because of the limitations of oxygen diffusion (chronic hypoxia)
and the temporary occlusion of vessels or the slowing of blood
flow (limitations of perfusion, or acute hypoxia) (Brown, 1979).
Additionally, it has recently been demonstrated that modest hyper-
thermia causes an increase in tumourpO2, probably resulting from
an improvement in the supply ofoxygen via an increase in tumour
blood flow (Secomb et al, 1995; Iwata et al, 1996; Song et al,
1996). Consequently, we analysed the time courses of changes in
the hypoxic fractions oftotal tumour and Q-cell populations within
SCC VII solid tumours after mild hyperthermia, using our devel-
oped method for selectively detecting the responses ofQ cells.
The plating efficiencies and MN frequencies of cells from
animals not treated with radiation (Table 1) showed that the mild
hyperthermia employed here could not induce thermal cytotoxi-
city. Additionally, it has been reported that this level of modest
hyperthermia cannot delay tumour growth (Nishimura et al, 1990)
or draw direct thermal radiosensitization (Dewey, 1994).
Similar to the results ofourprevious study using X-ray irradiation
to treat solid tumours (Masunaga etal, 1991), weconfirmed here that
the sensitivity toy-irradiation ofQ cells is lowerthan that ofthe total
tumour cell population, partly because Q cells contain significantly
higher hypoxic fractions than total tumour cells. This is consistent
with previous reports and with the hypothesis concerning the pres-
ence of Q cell populations in solid tumours (Dethlefsen, 1980). The
presence of clonogenic Q cells with a low radiosensitivity is now
thought to be one ofthe causes ofradiation therapy failure.
We have shown previously that in SCC VII tumours the hypoxic
fraction ofP cells includes alarge proportion ofthe acutely hypoxic
fraction and a small proportion of the chronically hypoxic fraction,
and that the Q cells are largely composed ofthe chronically hypoxic
fraction (Masunaga et al, 1993). In this study, we demonstrated that
mild heat treatment might preferentially oxygenate the HF ofQ cell
populations, and the decrease in the HF ofQ cells lasted longerthan
that in the HF of the total cell population. These observations
showed that mild heat treatment might mainly oxygenate the chron-
ically hypoxic fraction rather than the acutely hypoxic fraction in
solid tumours. Thus, an improvement in oxygen supply through an
increase in tumour blood flow induced by modest temperature
hyperthermia, appeared to preferentially oxygenate radiobiologi-
cally diffusion-limited chronically hypoxic cell populations.
Consequently, low thermal dose clinical hyperthermia might
result in radiosensitization because of its potential to oxygenate
the chronically hypoxic fractions in heated tumours when
combined with conventional radiotherapy. Moreover, the time
courses of changes in the decrease in the HFs of total and Q cell
populations after mild heating, suggested that irradiation within 12
h after mild heating may be a promising therapeutic method for
controlling radioresistant Q tumour cells, especially when it is
difficult to elevate the tumour temperature sufficiently to cause
vascular damage, kill tumour cells, and directly radiosensitize the
tumour cells within solid tumours. Mild heat treatment may be a
useful method for releasing the chronically hypoxic fraction when
traditional techniques such as hyperbaric oxygen or carbogen
inhalation cannot be used. In future, we have a plan to make sure
ofthe usefulness ofirradiation within 12 h after mild heating using
a tumour control dose (TCD50) assay.
Q cells are defined as those cells that are not actively prolifer-
ating during the time in which measurements are obtained
(Dethlefsen, 1980). We used the term 'quiescent' to include all
cells out of cycle, irrespective of the reason. The Go state, in
contrast, is confined to viable cells that are out of cycle under
normal physiological conditions (i.e. not because ofnutrient depri-
vation), and that can be induced to recruit into active proliferation
by appropriate stimuli (Jackson, 1989). The best examples ofthese
cells are to be found in normal intact tissues (liver, salivary gland,
etc.). As flow cytometric analysis oftumour cells is now possible,
we also plan to examine the relationship between the response of
Q-cell populations and changes in the cell cycle by flow karyotype
analysis.
The Q-cell assay method used here, which combines a cyto-
kinesis-block MN frequency assay with immunofluorescence
staining for BrdU after continuously labelling P cells with BrdU,
appears to be useful fordetermining the sensitivity ofQ-cell popu-
lations in solid tumours to radiation. Using this method, we plan to
investigate the responses of Q cells to treatments with radiation
and chemotherapeutic agents and/or hypoxic cell sensitizers, as
well as their responses to high linear energy transfer radiation,
including thermal and/or epithermal neutrons.
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